A study in piglets conducted by researchers at the University of Alberta has found that Vegaven, a novel plant-based lipid emulsion containing Buglossoides arvensis seed oil, provides major benefits when used for parenteral nutrition, namely protective anti-inflammatory effects in the liver.
This is in accordance with previous research by the same group, where Vegaven was superior to lipid emulsions based on soybean oil (Intralipid) or fish oil (Omegaven).
Notably, researchers found that Vegaven could achieve this better than traditional soybean, olive and fish oils, which are the commonly used lipid emulsions.
This study highlights the great potential of the plant oil-based lipid emulsion in life-saving parenteral nutrition of vulnerable patients such as preterm infants, critically ill patients and those who have undergone surgery.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Nutraceutical Business Review.
Subscribe now Already a subscriber? Sign in here.